CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.35
-0.49 (-6.25%)
At close: Feb 5, 2026, 4:00 PM EST
7.53
+0.18 (2.45%)
Pre-market: Feb 6, 2026, 5:34 AM EST

CorMedix Revenue

CorMedix had revenue of $104.28M in the quarter ending September 30, 2025, with 810.22% growth. This brings the company's revenue in the last twelve months to $211.57M, up 1,625.42% year-over-year. In the year 2024, CorMedix had annual revenue of $43.47M.

Revenue (ttm)
$211.57M
Revenue Growth
+1,625.42%
P/S Ratio
2.32
Revenue / Employee
$3,296,980
Employees
65
Market Cap
579.10M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202443.47M--
Dec 31, 2023---
Dec 31, 202265.41K-125.53K-65.74%
Dec 31, 2021190.94K-48.30K-20.19%
Dec 31, 2020239.23K-44.04K-15.55%
Dec 31, 2019283.27K-146.53K-34.09%
Dec 31, 2018429.80K100.47K30.51%
Dec 31, 2017329.33K105.22K46.95%
Dec 31, 2016224.11K13.98K6.65%
Dec 31, 2015210.13K20.86K11.02%
Dec 31, 2014189.27K187.27K9,358.97%
Dec 31, 20132.00K--
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Rigel Pharmaceuticals282.08M
Gossamer Bio44.05M
MeiraGTx Holdings27.42M
Prime Medicine5.98M
Altimmune20.00K
Revenue Rankings